Publication:
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.

Simple item page
dc.contributor.authorRaj, Kavita
dc.contributor.authorEikema, Dirk-Jan
dc.contributor.authorSheth, Vipul
dc.contributor.authorKoster, Linda
dc.contributor.authorde Wreede, Liesbeth C
dc.contributor.authorBlaise, Didier
dc.contributor.authorDi Grazia, Carmela
dc.contributor.authorKoc, Yener
dc.contributor.authorPotter, Victoria
dc.contributor.authorChevallier, Patrice
dc.contributor.authorLopez-Corral, Lucia
dc.contributor.authorWu, Depei
dc.contributor.authorMielke, Stephan
dc.contributor.authorMaertens, Johan
dc.contributor.authorMeijer, Ellen
dc.contributor.authorHuynh, Anne
dc.contributor.authorPassweg, Jakob
dc.contributor.authorLuft, Thomas
dc.contributor.authorPérez-Simón, Jose Antonio
dc.contributor.authorCiceri, Fabio
dc.contributor.authorPiekarska, Agnieszka
dc.contributor.authorHayri Ozsan, G
dc.contributor.authorKröger, Nicolaus
dc.contributor.authorRobin, Marie
dc.contributor.authorYakoub-Agha, Ibrahim
dc.date.accessioned2023-05-03T13:26:13Z
dc.date.available2023-05-03T13:26:13Z
dc.date.issued2022-09-28
dc.description.abstractMyelodysplastic syndromes (MDS) are the second common indication for an Allo-HCT. We compared the outcomes of 1414 matched sibling (MSD) with 415 haplo-identical donors (HD) transplanted with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis between 2014 and 2017. The median age at transplant with MSD was 58 and 61 years for HD. The median time to neutrophil engraftment was longer for HD being 20 vs 16 days for MSD (p 
dc.identifier.doi10.1038/s41408-022-00729-y
dc.identifier.essn2044-5385
dc.identifier.pmcPMC9515068
dc.identifier.pmid36167679
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515068/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41408-022-00729-y.pdf
dc.identifier.urihttp://hdl.handle.net/10668/19519
dc.issue.number9
dc.journal.titleBlood cancer journal
dc.journal.titleabbreviationBlood Cancer J
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.number140
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAdult
dc.subject.meshCyclophosphamide
dc.subject.meshGraft vs Host Disease
dc.subject.meshHematopoietic Stem Cell Transplantation
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshMyelodysplastic Syndromes
dc.subject.meshNeoplasms
dc.subject.meshRecurrence
dc.subject.meshRetrospective Studies
dc.subject.meshSiblings
dc.subject.meshTransplantation Conditioning
dc.subject.meshUnrelated Donors
dc.titleComparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC9515068.pdf
Size:
1.14 MB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío
Instituto de Investigación Biomédica de Sevilla (IBIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía